These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Vancomycin binding to low-affinity ligands: delineating a minimum set of interactions necessary for high-affinity binding. Loll PJ; Kaplan J; Selinsky BS; Axelsen PH J Med Chem; 1999 Nov; 42(22):4714-9. PubMed ID: 10579833 [TBL] [Abstract][Full Text] [Related]
8. The structural biology of molecular recognition by vancomycin. Loll PJ; Axelsen PH Annu Rev Biophys Biomol Struct; 2000; 29():265-89. PubMed ID: 10940250 [TBL] [Abstract][Full Text] [Related]
9. Dimerization of A82846B, vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides. Linsdell H; Toiron C; Bruix M; Rivas G; Menéndez M J Antibiot (Tokyo); 1996 Feb; 49(2):181-93. PubMed ID: 8621360 [TBL] [Abstract][Full Text] [Related]
10. Elucidation of the active conformation of vancomycin dimers with antibacterial activity against vancomycin-resistant bacteria. Nakamura J; Yamashiro H; Hayashi S; Yamamoto M; Miura K; Xu S; Doi T; Maki H; Yoshida O; Arimoto H Chemistry; 2012 Oct; 18(40):12681-9. PubMed ID: 22915313 [TBL] [Abstract][Full Text] [Related]
11. Structure of ristocetin A in complex with a bacterial cell-wall mimetic. Nahoum V; Spector S; Loll PJ Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):832-8. PubMed ID: 19622867 [TBL] [Abstract][Full Text] [Related]
12. Binding of vancomycin group antibiotics to D-alanine and D-lactate presenting self-assembled monolayers. Cooper MA; Fiorini MT; Abell C; Williams DH Bioorg Med Chem; 2000 Nov; 8(11):2609-16. PubMed ID: 11092546 [TBL] [Abstract][Full Text] [Related]
13. Molecular modeling of Gram-positive bacteria peptidoglycan layer, selected glycopeptide antibiotics and vancomycin derivatives modified with sugar moieties. Ślusarz R; Szulc M; Madaj J Carbohydr Res; 2014 May; 389():154-64. PubMed ID: 24685455 [TBL] [Abstract][Full Text] [Related]
15. Lipophilic vancomycin aglycon dimer with high activity against vancomycin-resistant bacteria. Yarlagadda V; Sarkar P; Manjunath GB; Haldar J Bioorg Med Chem Lett; 2015 Dec; 25(23):5477-80. PubMed ID: 26525861 [TBL] [Abstract][Full Text] [Related]
16. Configurational entropy and cooperativity between ligand binding and dimerization in glycopeptide antibiotics. Jusuf S; Loll PJ; Axelsen PH J Am Chem Soc; 2003 Apr; 125(13):3988-94. PubMed ID: 12656635 [TBL] [Abstract][Full Text] [Related]
17. The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics. Groves P; Searle MS; Mackay JP; Williams DH Structure; 1994 Aug; 2(8):747-54. PubMed ID: 7994574 [TBL] [Abstract][Full Text] [Related]
18. The role of sugar residues in molecular recognition by vancomycin. Kaplan J; Korty BD; Axelsen PH; Loll PJ J Med Chem; 2001 May; 44(11):1837-40. PubMed ID: 11356118 [TBL] [Abstract][Full Text] [Related]
19. A mechanistic study of enantiomeric separation with vancomycin and balhimycin as chiral selectors by capillary electrophoresis. Dimerization and enantioselectivity. Kang J; Bischoff D; Jiang Z; Bister B; Süssmuth RD; Schurig V Anal Chem; 2004 Apr; 76(8):2387-92. PubMed ID: 15080752 [TBL] [Abstract][Full Text] [Related]
20. Binding of a dimeric derivative of vancomycin to L-Lys-D-Ala-D-lactate in solution and at a surface. Rao J; Yan L; Lahiri J; Whitesides GM; Weis RM; Warren HS Chem Biol; 1999 Jun; 6(6):353-9. PubMed ID: 10375541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]